Recently, BRD4 was identified as a transcriptional repressor of autophagy and lysosomal biogenesis, independent of TFEB/TFE3/MITF-mediated mechanisms
Mads Krogsgaard Thomsen, at the time R&D executive in the Diabetes Care Division of Novo Nordisk, undertook the initiative to synthesize long-acting GLP-1 analogues (Fig
A half-life is the amount of time it takes for the concentration of a drug in your body to reduce by exactly half
What GLP-1 programs have no subscription or membership fee
Complete a quick health questionnaire
209 Davis ME, Zuckerman JE, Choi CHJ, Seligson D, Tolcher A, Alabi CA, Yen Y, Heidel JD, Ribas A